Navigation Links
2007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery
Date:3/13/2008

CHICAGO, March 13 /PRNewswire/ -- The American Academy of Cosmetic Surgery (AACS) announces the results of its 2007 Procedural Data and since 2002, the average age for patients receiving invasive cosmetic surgery has increased.

From 2002 to 2007, the mean age of patients seeking the top ten most performed invasive procedures has increased by two years. The invasive procedures that have seen the largest increase include liposuction, sclerotherapy, facelift and forehead lift. Following suit with this trend, Botox(R), the most popular non-invasive procedure, has experienced a two year increase in average age.

The aging population and the baby boomers are likely to be the driving force behind these increases. Baby boomers make up approximately 28% of the national population, according to 2006 census reports. Baby boomers fall in the 42-64 age range and the average age of those receiving invasive and non-invasive procedures are 42.6 and 42.4, respectively.

"Cosmetic surgeons are seeing anywhere between a one to three year increase in our patient's age," said Dr. Steven Hopping, MD, President of the AACS. "It appears that as baby boomers grow older, so does our clientele."

Of note among the findings: for the eighth year in a row, liposuction proved to be the nation's top cosmetic surgical procedure with Botox(R) injections being the top non-invasive cosmetic surgery procedure.

There has been a 13.7% increase in the percentage of men from 2002 to 2007 who have had cosmetic surgery, showing a growing trend among men. Among patients treated, 80% were women and 20% were male.

The report includes data on the prevalence of various cosmetic surgery procedures, with a breakdown of men and women. The survey also showed that of all cosmetic procedures performed, 23% were surgical, with the remaining 77% being non-surgical procedures.

The report also highlights the price ranges of the procedures performed.

The top three
'/>"/>

SOURCE The American Academy of Cosmetic Surgery
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life
2. 20-City Zagat Survey(R) Guide Spotlights Outdoor Destinations and Offers Allergy Management Tips
3. The Disappearing Toothbrush: Survey Reveals Kids Top Excuses to Avoid Brushing
4. New Survey Shows Solutions to Improve Latinos Access to Health Care in California
5. Part-Time Practice Trends Intensify Physician Shortage According to AMGA and Cejka Search 2007 Physician Retention Survey
6. New Harris Survey Finds That Most Baby Boomers Underestimate Disability Risk
7. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
8. High Numbers of Children With Special Needs Have Health Insurance, Regular Caregivers, HRSA Survey Finds
9. Template-Free Electronic Medical Record Wins AAFP User Satisfaction Survey.
10. New WBL Foundation Survey Shows Robust Pool of Women Available for Corporate Board Service
11. New Survey Shows 90 Percent of Women Do Not Fully Understand the Calories They Eat
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 1FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 2FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 3FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 4VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 1VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 2VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 3Americans Spend Billions on Alternative Medicine 53255 1Americans Spend Billions on Alternative Medicine 53255 2Americans Spend Billions on Alternative Medicine 53255 3
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5